Search
for
Sort by
Research 211–240 of 1000+
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
- Dermatoses of pregnancy
- The PDGF/PDGFR pathway as a drug target
- Recognition and management of <i>Staphylococcus aureus</i> toxin‐mediated disease
- Sex differences in COVID-19: the role of androgens in disease severity and progression
- Significant Correction of Disease after Postnatal Administration of Recombinant Ectodysplasin A in Canine X-Linked Ectodermal Dysplasia
- A History of Drug Advertising: The Evolving Roles of Consumers and Consumer Protection
- Fibromyalgia, Systemic Lupus Erythematosus (SLE), and Evaluation of SLE Activity
- Long-term complications of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN): the spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multidisciplinary follow-up
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- What causes hidradenitis suppurativa ?—15 years after
- Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
- Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Costunolide—A Bioactive Sesquiterpene Lactone with Diverse Therapeutic Potential
- Toxic Epidermal Necrolysis
- Exosomes and Their Bioengineering Strategies in the Cutaneous Wound Healing and Related Complications: Current Knowledge and Future Perspectives
- Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Global Burden of Skin Disease as Reflected in<i>Cochrane Database of Systematic Reviews</i>
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- The role of nuclear hormone receptors in cutaneous wound repair
- An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner
- COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Graft-versus-host disease
- JAK inhibitors and alopecia areata
- Essential syphilitic alopecia revisited
- Autoimmunity and autoimmune co-morbidities in psoriasis
- Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart